JPS6013718A - Ｂ型肝炎ワクチン - Google Patents

Ｂ型肝炎ワクチン

Info

Publication number
JPS6013718A
JPS6013718A JP58122945A JP12294583A JPS6013718A JP S6013718 A JPS6013718 A JP S6013718A JP 58122945 A JP58122945 A JP 58122945A JP 12294583 A JP12294583 A JP 12294583A JP S6013718 A JPS6013718 A JP S6013718A
Authority
JP
Japan
Prior art keywords
gel
freeze
aluminum
vaccine
hbsag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58122945A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0437806B2 (enExample
Inventor
Kyosuke Mizuno
水野　喬介
Yoshimitsu Ishihara
石原　義光
Tetsuo Kawahara
川原　哲夫
Shinya Otomo
信也 大友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14848502&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS6013718(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP58122945A priority Critical patent/JPS6013718A/ja
Priority to AU29993/84A priority patent/AU572162B2/en
Priority to KR1019840003814A priority patent/KR910005888B1/ko
Priority to AT84107773T priority patent/ATE41309T1/de
Priority to DE8484107773T priority patent/DE3477139D1/de
Priority to EP84107773A priority patent/EP0130619B1/en
Priority to CA000458226A priority patent/CA1237076A/en
Publication of JPS6013718A publication Critical patent/JPS6013718A/ja
Publication of JPH0437806B2 publication Critical patent/JPH0437806B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP58122945A 1983-07-05 1983-07-05 Ｂ型肝炎ワクチン Granted JPS6013718A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP58122945A JPS6013718A (ja) 1983-07-05 1983-07-05 Ｂ型肝炎ワクチン
AU29993/84A AU572162B2 (en) 1983-07-05 1984-06-28 Hepatitis b vaccine
KR1019840003814A KR910005888B1 (ko) 1983-07-05 1984-07-02 동결건조 b형 간염 왁진의 제조방법
AT84107773T ATE41309T1 (de) 1983-07-05 1984-07-04 Hepatitis-b-vakzin und verfahren zur herstellung.
DE8484107773T DE3477139D1 (en) 1983-07-05 1984-07-04 Hepatitis b vaccine and method for its preparation
EP84107773A EP0130619B1 (en) 1983-07-05 1984-07-04 Hepatitis b vaccine and method for its preparation
CA000458226A CA1237076A (en) 1983-07-05 1984-07-05 Hepatitis b vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58122945A JPS6013718A (ja) 1983-07-05 1983-07-05 Ｂ型肝炎ワクチン

Publications (2)

Publication Number Publication Date
JPS6013718A true JPS6013718A (ja) 1985-01-24
JPH0437806B2 JPH0437806B2 (enExample) 1992-06-22

Family

ID=14848502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58122945A Granted JPS6013718A (ja) 1983-07-05 1983-07-05 Ｂ型肝炎ワクチン

Country Status (7)

Country Link
EP (1) EP0130619B1 (enExample)
JP (1) JPS6013718A (enExample)
KR (1) KR910005888B1 (enExample)
AT (1) ATE41309T1 (enExample)
AU (1) AU572162B2 (enExample)
CA (1) CA1237076A (enExample)
DE (1) DE3477139D1 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
KR20030025480A (ko) * 2001-09-21 2003-03-29 보령제약 주식회사 약독화 수두 생바이러스 백신용 무단백질 안정화제
JP2003535119A (ja) * 2000-06-08 2003-11-25 パウダージェクト ワクチンズ，インコーポレーテッド 粉末組成物
JP2012520849A (ja) * 2009-03-19 2012-09-10 インターベツト・インターナシヨナル・ベー・ベー 動物の所定の群れに対して投与するためのワクチンのその場（ｉｎｓｉｔｕ）構成
JP2013523705A (ja) * 2010-03-31 2013-06-17 スタビリテック リミテッド ミョウバンアジュバントおよびミョウバンアジュバント化ワクチンの保存方法
JPWO2013012022A1 (ja) * 2011-07-19 2015-02-23 中外製薬株式会社 アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
JPWO2017179614A1 (ja) * 2016-04-15 2019-02-21 富士フイルム株式会社 マイクロニードルアレイ

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
JP3626996B2 (ja) * 1992-05-23 2005-03-09 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
AU4932493A (en) * 1992-09-25 1994-04-26 Dynagen, Inc. An immunobooster for delayed release of immunogen
US6051238A (en) * 1996-12-20 2000-04-18 Merck & Co., Inc. Stabilizers for lyophilized mumps vaccines
US6290967B1 (en) * 1996-12-20 2001-09-18 Merck & Co., Inc. Stabilizers for lyophilized vaccines
UA79735C2 (uk) 2000-08-10 2007-07-25 Глаксосмітклайн Байолоджікалз С.А. Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах
WO2002101412A2 (en) 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
US20060228369A1 (en) * 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
AU2007317847B2 (en) 2006-11-07 2013-10-31 Sanofi Pasteur Biologics, Llc Stabilization of vaccines by lyophilization
EP2898890B1 (en) 2010-03-31 2019-08-21 Stabilitech Biopharma Ltd Stabilisation of viral particles
CA2795047C (en) 2010-03-31 2019-04-09 Stabilitech Ltd. Stabilised liquid formulations
AU2012272788B2 (en) 2011-06-24 2016-10-20 Merck Sharp & Dohme Llc HPV vaccine formulations comprising aluminum adjuvant and methods of producing same
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879202A (en) * 1954-11-05 1959-03-24 American Cyanamid Co Stabilization of live viral vaccines by hexahydric alcohols
DE1617457A1 (de) * 1966-12-16 1972-04-20 Erba Carlo Spa Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte
DE1617350C3 (de) * 1967-06-22 1979-09-06 Behringwerke Ag, 3550 Marburg Verfahren zur Inaktivierung von biologischem Material
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
JPS5523253B2 (enExample) * 1973-12-28 1980-06-21

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
JP2003535119A (ja) * 2000-06-08 2003-11-25 パウダージェクト ワクチンズ，インコーポレーテッド 粉末組成物
KR20030025480A (ko) * 2001-09-21 2003-03-29 보령제약 주식회사 약독화 수두 생바이러스 백신용 무단백질 안정화제
JP2012520849A (ja) * 2009-03-19 2012-09-10 インターベツト・インターナシヨナル・ベー・ベー 動物の所定の群れに対して投与するためのワクチンのその場（ｉｎｓｉｔｕ）構成
JP2013523705A (ja) * 2010-03-31 2013-06-17 スタビリテック リミテッド ミョウバンアジュバントおよびミョウバンアジュバント化ワクチンの保存方法
JPWO2013012022A1 (ja) * 2011-07-19 2015-02-23 中外製薬株式会社 アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
US9574005B2 (en) 2011-07-19 2017-02-21 Chugai Seiyaku Kabushiki Kaisha Stable Protein-containing preparation containing argininamide or analogous compound thereof
US10898572B2 (en) 2011-07-19 2021-01-26 Chugai Seiyaku Kabushiki Kaisha Stable protein-containing preparation containing argininamide or analogous compound thereof
JPWO2017179614A1 (ja) * 2016-04-15 2019-02-21 富士フイルム株式会社 マイクロニードルアレイ
US11266822B2 (en) 2016-04-15 2022-03-08 Fujifilm Corporation Microneedle array

Also Published As

Publication number Publication date
EP0130619A3 (en) 1985-04-10
EP0130619B1 (en) 1989-03-15
JPH0437806B2 (enExample) 1992-06-22
AU572162B2 (en) 1988-05-05
EP0130619A2 (en) 1985-01-09
CA1237076A (en) 1988-05-24
KR850002277A (ko) 1985-05-10
ATE41309T1 (de) 1989-04-15
DE3477139D1 (en) 1989-04-20
KR910005888B1 (ko) 1991-08-06
AU2999384A (en) 1985-01-10

Similar Documents

Publication Publication Date Title
JPS6013718A (ja) Ｂ型肝炎ワクチン
CA1183084A (en) Intravenously injectable immune serum globulin
US4499073A (en) Intravenously injectable immune serum globulin
NL7905220A (nl) Antitrombinepreparaat en werkwijze ter bereiding ervan.
CA1331135C (en) _-globulin injectable solutions
JP5357391B2 (ja) 液状形態及び凍結乾燥形態の免疫グロブリンｇ組成物用安定化配合物
JPS60193925A (ja) 凍結乾燥製剤化ワクチン
JPH07206709A (ja) 高濃度免疫グロブリン製剤及びその製造方法
EP2258402A2 (en) Dried composition
JPH089547B2 (ja) 改良された静脈内投与可能な免疫性グロブリン組成物
JPH0348171B2 (enExample)
US4168303A (en) Lyophilized native gamma globulin preparation for intravenous administration
JPH01279843A (ja) 凍結乾燥ａ型肝炎ワクチン
JPS5967228A (ja) 寒冷不溶性グロブリンの凍結乾燥方法
JPS59157017A (ja) 静脈投与用γ−グロブリン製剤
KR950010321B1 (ko) 인간 트롬빈 제제의 가열처리방법
JPH0118080B2 (enExample)
JPS5840532B2 (ja) Ｉｇａ オヨビ ｉｇｍ ノネツアンテイカホウ
JPS62289523A (ja) 静脈投与用免疫グロブリンの加熱処理方法
JP2717638B2 (ja) 人血液凝固第ｉｘ因子含有製剤
JPS5822445B2 (ja) 安定な固体の人血漿コリンエステラ−ゼ製剤の製法
JPH0635391B2 (ja) 人血液凝固第▲ｉｘ▼因子含有製剤の加熱処理方法
Hansen Influence of chlorophenoxyisobutyrate (CPIB) on thyroid parameters
JPS59500812A (ja) 血漿蛋白質の熱安定化
JPS59181215A (ja) ヘマチンの安定化法